COMMUNIQUÉS West-GlobeNewswire

VITAS® Healthcare Introduces Premier Hospice Care in Bakersfield and Fresno

01/10/2024 - 15:18

BAKERSFIELD, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- To meet the growing need for quality end-of-life care in California’s Central Valley, VITAS Healthcare hospice services are now available for residents of [...]

L'association TALVEY®▼ (talquetamab) et DARZALEX® (daratumumab) en sous-cutané (SC) montre des réponses profondes et durables chez les patients atteints d'un myélome multiple récidivant ou réfractaire

01/10/2024 - 15:17

Les données mises à jour présentent un taux de réponse global de 100 pour cent, parmi lesquels 56 pour cent des patients ont obtenu une réponse complète ou supérieure avec un schéma d'administration hebdomadaire. Cela [...]

Positron Corporation Launches Prime Rental Program for Pet-Ct Systems

01/10/2024 - 15:15

Niagara Falls, NY, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission [...]

PacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in Singapore

01/10/2024 - 15:05

The new lab will leverage PacBio’s HiFi sequencing technology to broaden access to highly accurate long-read sequencing and multi-omics solutions in Southeast Asia SINGAPORE, Oct. 01, 2024 (GLOBE NEWSWIRE) -- PacBio ( [...]

Verana Health Announces Launch of Qdata® BPH

01/10/2024 - 15:00

Research-ready data module for the drug and device lifecycle contains real-world insights from 1.6 million patients, offering a deep understanding of disease progression, management and comorbidities for patients with [...]

GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING

01/10/2024 - 15:00

Updated preclinical data for the continuous blood glucose monitor to be presented at major diabetes technology conference Rutherford, NJ, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” [...]

Biomea Announces Formation of Global Scientific Advisory Board with 22 World-Renowned Diabetes Experts

01/10/2024 - 15:00

International diabetes pioneers and thought leaders from 11 countries will work with Biomea leadership to unlock the potential of menin science and beta cell biology to advance BMF-219 and Biomea’s evolving pipeline [...]

Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

01/10/2024 - 15:00

DURHAM, N.C., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has signed a definitive agreement [...]

Guardion Health Sciences Announces Adoption of Plan of Dissolution and Liquidation; Appointment of Interim President and CEO

01/10/2024 - 15:00

Plan includes Voluntary Delisting of Common Stock from Nasdaq and Suspension of SEC Reporting Obligations HOUSTON, TEXAS, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or [...]

Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs

01/10/2024 - 14:45

SEATTLE and VANCOUVER, British Columbia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company dedicated to the global development and commercialization of [...]

Merakris Therapeutics Introduces Dermacyte® AC Matrix: A Lyophilized Amnion Chorion Allograft

01/10/2024 - 14:37

Merakris to showcase new Lyophilized Amnion Chorion Allograft at the Fall Symposium for Advanced Wound Care (SAWC) in Las Vegas at booth 440 on October 2-5, 2024. RESEARCH TRIANGLE PARK, N.C., Oct. 01, 2024 (GLOBE [...]

Evoke Pharma Announces Proceeds from Existing Warrants and Board Expansion

01/10/2024 - 14:30

Nantahala to nominate 2 board seats Portion of the proceeds received from warrants executed at $8.16/share SOLANA BEACH, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty [...]

TerrAscend Closes on Remaining US$26 Million Draw of US$140 Million Debt Financing

01/10/2024 - 14:30

Proceeds from second draw used to pay down higher interest Michigan debt TORONTO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND, OTCQX: TSNDF), a leading North American [...]

GPS Marine Adopts Intelligent Bio Solutions’ Fingerprint Drug Testing Technology to Boost Workplace Safety in Maritime Services

01/10/2024 - 14:30

NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]

Teva Announces Launch of the First and Only Generic Version of Sandostatin® LAR Depot (octreotide acetate for injectable suspension), in the U.S.

01/10/2024 - 14:29

This first-to-market launch showcases Teva’s proven strengths in complex generic formulations and enhances Teva’s strategic goal of sustaining a generic powerhouse . O ctreotide acetate for injectable suspension is [...]

AMN Healthcare Announces CFO Transition

01/10/2024 - 14:15

Jeffrey Knudson to Step Down as CFO Following Company’s Q3 Report Company Expects to Announce New Leader in Expanded CFO/COO Role Prior to November 8 Reaffirms Third Quarter 2024 Outlook DALLAS, Oct. 01, 2024 (GLOBE [...]

Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024

01/10/2024 - 14:03

CORAL GABLES, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and [...]

Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

30/09/2024 - 22:45

SOUTH SAN FRANCISCO, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on September 30, 2024 it granted stock options to purchase an aggregate of 120,000 shares of [...]

Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, 2024

30/09/2024 - 22:30

TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its financial results for the third quarter of 2024 on [...]